Proteome Sciences plc (PRM) Ordinary 1p
0.24p
(9.23%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.24p
(9.23%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.24p
(9.23%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
2.60p
2.99p
5.40p
£7.67 million
2.60p
2.02p
1.31p
n/a
0.20p (7.14%) Previous:
0.20p
355,003
n/a
100,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | 4.89 | 5.03 |
| Profit before tax (£m) | (3.25) | (2.42) |
| Adjusted EPS (p): | (1.15) | (0.83) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Proteome secures third contract from US biopharma client
8 December 2025 09:39
-
Proteome secures $1m-plus contract with US biopharma firm
21 February 2025 11:32
-
Proteome Sciences gives bullish outlook for 2025
23 December 2024 11:56
-
Substantial contract for Proteome Sciences
8 December 2025 07:00
-
Appointment of Nominated Adviser and Broker
25 November 2025 07:00
-
Interim Results
25 September 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.